181 related articles for article (PubMed ID: 23896933)
21. Development of 14-epi-19-nortachysterol and its unprecedented binding configuration for the human vitamin D receptor.
Sawada D; Tsukuda Y; Saito H; Kakuda S; Takimoto-Kamimura M; Ochiai E; Takenouchi K; Kittaka A
J Am Chem Soc; 2011 May; 133(18):7215-21. PubMed ID: 21500802
[TBL] [Abstract][Full Text] [Related]
22. A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation.
Greising DM; Schwartz Z; Posner GH; Sylvia VL; Dean DD; Boyan BD
J Cell Physiol; 1997 Jun; 171(3):357-67. PubMed ID: 9180905
[TBL] [Abstract][Full Text] [Related]
23. Proposal of potent inhibitors for vitamin-D receptor based on ab initio fragment molecular orbital calculations.
Takeda R; Kobayashi I; Suzuki R; Kawai K; Kittaka A; Takimoto-Kamimura M; Kurita N
J Mol Graph Model; 2018 Mar; 80():320-326. PubMed ID: 29433089
[TBL] [Abstract][Full Text] [Related]
24. Vitamin D analogue-specific recruitment of vitamin D receptor coactivators.
Issa LL; Leong GM; Sutherland RL; Eisman JA
J Bone Miner Res; 2002 May; 17(5):879-90. PubMed ID: 12009019
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms.
Haussler MR; Jurutka PW; Mizwicki M; Norman AW
Best Pract Res Clin Endocrinol Metab; 2011 Aug; 25(4):543-59. PubMed ID: 21872797
[TBL] [Abstract][Full Text] [Related]
26. Why do we need a three-dimensional architecture of the ligand-binding domain of the nuclear 1alpha,25-dihydroxyvitamin D(3) receptor?
Mohr SC; Swamy N; Xu W; Ray R
Steroids; 2001; 66(3-5):189-201. PubMed ID: 11179726
[TBL] [Abstract][Full Text] [Related]
27. Covalent labeling of nuclear vitamin D receptor with affinity labeling reagents containing a cross-linking probe at three different positions of the parent ligand: structural and biochemical implications.
Kaya T; Swamy N; Persons KS; Ray S; Mohr SC; Ray R
Bioorg Chem; 2009 Apr; 37(2):57-63. PubMed ID: 19223058
[TBL] [Abstract][Full Text] [Related]
28. NMR assignments of tryptophan residue in apo and holo LBD-rVDR.
Sicinska W; Westler WM; DeLuca HF
Proteins; 2005 Nov; 61(3):461-7. PubMed ID: 16130132
[TBL] [Abstract][Full Text] [Related]
29. Conformationally restricted analogs of 1 alpha, 25-dihydroxyvitamin D3 and its 20-epimer: compounds for study of the three-dimensional structure of vitamin D responsible for binding to the receptor.
Yamamoto K; Sun WY; Ohta M; Hamada K; DeLuca HF; Yamada S
J Med Chem; 1996 Jul; 39(14):2727-37. PubMed ID: 8709103
[TBL] [Abstract][Full Text] [Related]
30. Structure-function relationships of vitamin D including ligand recognition by the vitamin D receptor.
Yamada S; Shimizu M; Yamamoto K
Med Res Rev; 2003 Jan; 23(1):89-115. PubMed ID: 12424754
[TBL] [Abstract][Full Text] [Related]
31. Ligand-specific structural changes in the vitamin D receptor in solution.
Singarapu KK; Zhu J; Tonelli M; Rao H; Assadi-Porter FM; Westler WM; DeLuca HF; Markley JL
Biochemistry; 2011 Dec; 50(51):11025-33. PubMed ID: 22112050
[TBL] [Abstract][Full Text] [Related]
32. Structure-activity relationship of nonsecosteroidal vitamin D receptor modulators.
Yamada S; Makishima M
Trends Pharmacol Sci; 2014 Jul; 35(7):324-37. PubMed ID: 24865943
[TBL] [Abstract][Full Text] [Related]
33. Structural investigation of the ligand binding domain of the zebrafish VDR in complexes with 1alpha,25(OH)2D3 and Gemini: purification, crystallization and preliminary X-ray diffraction analysis.
Ciesielski F; Rochel N; Mitschler A; Kouzmenko A; Moras D
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):55-9. PubMed ID: 15225747
[TBL] [Abstract][Full Text] [Related]
34. Butyl pocket formation in the vitamin D receptor strongly affects the agonistic or antagonistic behavior of ligands.
Yoshimoto N; Sakamaki Y; Haeta M; Kato A; Inaba Y; Itoh T; Nakabayashi M; Ito N; Yamamoto K
J Med Chem; 2012 May; 55(9):4373-81. PubMed ID: 22512505
[TBL] [Abstract][Full Text] [Related]
35. The unique tryptophan residue of the vitamin D receptor is critical for ligand binding and transcriptional activation.
Solomon C; Macoritto M; Gao XL; White JH; Kremer R
J Bone Miner Res; 2001 Jan; 16(1):39-45. PubMed ID: 11149488
[TBL] [Abstract][Full Text] [Related]
36. Crystal structures of the vitamin D nuclear receptor liganded with the vitamin D side chain analogues calcipotriol and seocalcitol, receptor agonists of clinical importance. Insights into a structural basis for the switching of calcipotriol to a receptor antagonist by further side chain modification.
Tocchini-Valentini G; Rochel N; Wurtz JM; Moras D
J Med Chem; 2004 Apr; 47(8):1956-61. PubMed ID: 15055995
[TBL] [Abstract][Full Text] [Related]
37. Ligand affinity, homodimerization, and ligand-induced secondary structural change of the human vitamin d receptor.
Falsone SF; Kurkela R; Chiarandini G; Vihko P; Kungl AJ
Biochem Biophys Res Commun; 2001 Aug; 285(5):1180-5. PubMed ID: 11478779
[TBL] [Abstract][Full Text] [Related]
38. Hybrid structural analogues of 1,25-(OH)2D3 regulate chondrocyte proliferation and proteoglycan production as well as protein kinase C through a nongenomic pathway.
Boyan BD; Posner GH; Greising DM; White MC; Sylvia VL; Dean DD; Schwartz Z
J Cell Biochem; 1997 Sep; 66(4):457-70. PubMed ID: 9282324
[TBL] [Abstract][Full Text] [Related]
39. A perspective on how the Vitamin D sterol/Vitamin D receptor (VDR) conformational ensemble model can potentially be used to understand the structure-function results of A-ring modified Vitamin D sterols.
Mizwicki MT; Bula CM; Bishop JE; Norman AW
J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):69-82. PubMed ID: 16055325
[TBL] [Abstract][Full Text] [Related]
40. Homologous up-regulation of vitamin D receptors is tissue specific in the rat.
Gensure RC; Antrobus SD; Fox J; Okwueze M; Talton SY; Walters MR
J Bone Miner Res; 1998 Mar; 13(3):454-63. PubMed ID: 9525346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
